Fibroblast Growth Factor Receptor 3 Mutations in Bladder Tumors Correlate with Low Frequency of Chromosome Alterations
Open Access
- 1 January 2008
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 10 (1), 1-7
- https://doi.org/10.1593/neo.07178
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Prospective Study of FGFR3 Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder CarcinomasJournal of Clinical Oncology, 2006
- A Simple and Fast Method for the Simultaneous Detection of Nine Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer and Voided UrineClinical Cancer Research, 2005
- Urothelial tumorigenesis: a tale of divergent pathwaysNature Reviews Cancer, 2005
- Molecular staging of bladder cancerBJU International, 2005
- A Molecular Signature in Superficial Bladder Carcinoma Predicts Clinical OutcomeClinical Cancer Research, 2005
- Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic CancerNeoplasia, 2005
- Coexistence of Copy Number Changes of Different Genes (INK4A, erbB-1, erbB-2, CMYC, CCND1 and ZNF217) in Urothelial TumorsTumor Biology, 2005
- The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.2001
- Patterns of chromosomal imbalances in muscle invasive bladder cancer.International Journal of Oncology, 2000
- Frequent activating mutations of FGFR3 in human bladder and cervix carcinomasNature Genetics, 1999